- Report
- May 2025
- 197 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 199 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- April 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- June 2025
- 146 Pages
Global
From €2658EUR$2,999USD£2,311GBP
- Report
- May 2025
- 140 Pages
Global
From €2658EUR$2,999USD£2,311GBP
- Report
- May 2024
- 128 Pages
Global
From €5761EUR$6,499USD£5,008GBP
Aminocaproic Acid is a hematological drug used to treat and prevent excessive bleeding. It is a synthetic derivative of the amino acid lysine and is used to inhibit the breakdown of fibrin, a protein involved in the clotting process. It is commonly used to treat conditions such as hemophilia, von Willebrand disease, and other bleeding disorders. It is also used to reduce bleeding during surgery and to treat excessive bleeding after childbirth.
Aminocaproic Acid is available in both oral and intravenous forms. It is generally well tolerated, with few side effects. Common side effects include nausea, vomiting, and diarrhea.
The Aminocaproic Acid market is a growing one, with increasing demand for the drug due to its effectiveness in treating and preventing excessive bleeding. It is widely used in hospitals and clinics, as well as in home care settings.
Some companies in the Aminocaproic Acid market include Pfizer, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more